Drugdiscovery >> Pharmaceutical Companies >> News
3771
Views
Agenus and Merck collaborate on research towards immune checkpoints - drugdiscovery.com
Agenus and Merck collaborate on research towards immune checkpoints - drugdiscovery.com


Agenus, an immuno-oncology company is going to contribute with Merck on developing therapeutic antibodies for immune checkpoints. This technique will open a new chapter in the field of cancer research too.
Read More >>


Tags: cancer, immune checkpoint, cancer research - May 1, 2014
Related Articles
2806
Views
Ablynx and Merck are collaborating Ablynx and Merck are collaborating
Ablynx is forming a colaboration wioth Merck to develop immunology drugs. The new partnership is focusing on predefined nanobody candidates and so called immun checkpoint modulators. Read More >>

Tags: immune checkpoint modulators, immune, ablynx, Merck

3173
Views
Ludwig Institute for Cancer Research and Agenus developing vaccine together Ludwig Institute for Cancer Research and Agenus developing vaccine together
The Ludwig Institute for Cancer Research and Agenus are named heir selection of three monoclonal antibody checkpoint modulators. The research is going to be a part of the companies' cacer vaccine proj Read More >>

Tags: Cancer vaccine, antibody, monoclonal antibody checkpoint modulators, Agenus, Ludwig Institute for Cancer Research

1668
Views
Continuing successful cooperation Continuing successful cooperation
A licensing deal signed between Cancer Research Technology, The Institute of Cancer Research, and Merck Serono, extends a successful initial alliance to discover and develop WNT pathway inhibitors to Read More >>

Tags: WNT pathway inhibitors, Cancer Research Technology, The Institute of Cancer Research, Merck Serono

4862
Views
Agenus shares fall after GSK’s MAGE-A3 failure in a Phase 3 trial Agenus shares fall after GSK’s MAGE-A3 failure in a Phase 3 trial
Glaxo’s MAGE-A3 immunotherapy treatment includes Agenus' SQ-21 Stimulon vaccine adjuvant which is designed to make drugs more effective. GSK reported that MAGE-A3 failed to meet its first goal in a Read More >>

Tags: Agenus, shares, GSK, melanoma clinical trial, MAGE-A3, SQ-21 Stimulon vaccine adjuvant, vaccine adjuvant

1445
Views
Merck takes part in the campaign to fight schistosomiasis in Sudan Merck takes part in the campaign to fight schistosomiasis in Sudan
Merck KGaA has donated to WHO 2.4 million Sudanese pounds worth schistosomiasis meds - praziquantel tablets for large-scale treatment of schistosomiasis in Sudan. Read More >>

Tags: Merck, donation, WHO, schistosomiasis, praziquantel, Sudan

3038
Views
MMV and Merck Serono are ciollaborating on findig anti malaria drug MMV and Merck Serono are ciollaborating on findig anti malaria drug
MMC and Marck Serono set up a group which is working on a chemical series that has shown significant antimalarial potential. The series has a unique profile as the compounds are long-acting and have d Read More >>

Tags: in vitro, malaria drug, Merck, MMV, malaaria

850
Views
EMA and TGA collaborate to find new orphan drugs EMA and TGA collaborate to find new orphan drugs
The European Medicines Agency and Australian Therapeutic Goods Administration announced that they are going to contribute on developing new orphan drugs and push them to clon Read More >>

Tags: European Medicines Agency, Australian Therapeutic Goods Administration, EMA,

3420
Views
Merck and Samsung are to develop new Diabetics Drug Merck and Samsung are to develop new Diabetics Drug
MK-1293, an insulin glargine candidate provides a good therapy for patients with diabetes type 1 and type 2. Merck and Samsung announced that they are going to collaborate over developing a more effec Read More >>

Tags: durg, diabetes, diabetes type 1, Merck, samsung

1866
Views
Bristol-Myers is going to end its drug development researches Bristol-Myers is going to end its drug development researches
Bristol-Myers Squibb announced that it will discontinue drug discovery in three disease branches. They also announced a lay-off affecting 70 to 75 researchers working on discovering drugs. Read More >>

Tags: Bristol-Myers, Squibb, BMY, Merck, MRK, AstraZeneca, AZN.LN, research, development, corporate

1359
Views
Amgen won't collaborate with GSK on Prolia Amgen won't collaborate with GSK on Prolia
Amgen announced that the company is goint to step back from collaborating with GSK. The two pharmaceutical giants have signed an contract and GSK commercialized the osteoporosis drug of Amgen However, Read More >>

Tags: GlaxoSimithKline, GSK, Prolia, osteoporosis, amgen

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013